PA

Pruthviraj Ashok Thorat

Active Director Director DIN 10915386
DIN 10915386 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Pruthviraj Ashok Thorat

Data last updated:

Pruthviraj Ashok Thorat is a Director at Polyset Life Science Private Limited (since 2025). The company operates in Pharma.

DIN 10915386
Primary Designation Director
Industry Pharma
First Appointment 21 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Polyset Life Science Private Limited U46497MH2025PTC438496
Director21 Jan 20252025Active

Board colleagues of Pruthviraj Ashok Thorat

NameDINCompanyDesignation
Namrata Pruthviraj Thorat10915385Polyset Life Science Private LimitedDirector

Directorship timeline

Open interactive timeline →
Polyset Life Science Private Limited
Premium access

Shareholding and investment profile for Pruthviraj Ashok Thorat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pruthviraj Ashok Thorat

Pruthviraj Ashok Thorat currently holds 1 directorship: Polyset Life Science Private Limited (Director, since 21 Jan 2025).

Pruthviraj Ashok Thorat was first appointed on 21 Jan 2025 as Director at Polyset Life Science Private Limited.

The current boards of Pruthviraj Ashok Thorat's companies include Namrata Pruthviraj Thorat (Polyset Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available